METACARE CO., Ltd. (KRX:118000)
345.00
+11.00 (3.29%)
At close: Jun 5, 2025, 3:30 PM KST
METACARE CO. Revenue
METACARE CO. had revenue of 5.99B KRW in the quarter ending March 31, 2025, with 22.67% growth. This brings the company's revenue in the last twelve months to 21.32B, up 19.27% year-over-year. In the year 2024, METACARE CO. had annual revenue of 20.21B with 17.10% growth.
Revenue (ttm)
21.32B
Revenue Growth
+19.27%
P/S Ratio
2.67
Revenue / Employee
666.11M
Employees
32
Market Cap
56.85B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 20.21B | 2.95B | 17.10% |
Dec 31, 2023 | 17.26B | -1.84B | -9.64% |
Dec 31, 2022 | 19.10B | 484.98M | 2.61% |
Dec 31, 2021 | 18.61B | 11.99B | 181.12% |
Dec 31, 2020 | 6.62B | -49.53B | -88.21% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
LigaChem Biosciences | 146.42B |